Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Simplify and Speed Up Your COVID-19 Testing Process with LabDash

ALBANY, OREGON – Concept Systems and WVT Laboratory have engineered LabDash, a web-based sample tracking system designed to simplify and speed up the COVID-19 testing process, and are excited to make it available to patients, private sponsors, providers and labs. LabDash has been key in WVT’s ability to have scaled to the highest volume COVID-19…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Pro AV Today on MarketScale.

Share
Simplify and Speed Up Your COVID-19 Testing Process with LabDash

ALBANY, OREGON – Concept Systems and WVT Laboratory have engineered LabDash, a web-based sample tracking system designed to simplify and speed up the COVID-19 testing process, and are excited to make it available to patients, private sponsors, providers and labs. LabDash has been key in WVT’s ability to have scaled to the highest volume COVID-19 testing lab in Oregon. LabDash also works with the Oregon Health Authority and others to provide fast and acurate COVID-19 testing results.

Quick and accurate testing is paramount to improved diagnosis and treatment of the disease and to generate more positive patient outcomes during the pandemic. LabDash makes this possible by simplifying the patient testing process; collection, receipt at the labs, result notification and reporting.

With individual accounts for patients, healthcare providers, sponsors and labs, LabDash has tailored interfaces for each and drastically reduces the complexity of data collection and reporting, while ensuring data accuracy and privacy throughout the process.

The lifecycle and test kit tracking process of LabDash looks like this:

  • The lab generates and assigns barcodes to providers, sponsors and individual patients who have requested tests. The lab is then empowered to follow their own standard procedures for test kit distribution.
  • Providers and sponsors facilitate testing as needed. Providers and patients enter the barcode and patient information to correlate the two when the sample is collected, and write the patient’s initials on the test tube.
  • When tests arrive back at the lab, lab technician scan each sample barcode into LabDash to mark the sample as “received.” The patient’s initials appear on the screen and the technician verifies that it matches what’s written on the test tube – no more manual entry of information.
  • After processing the samples, lab technicians upload the test results to LabDash. Providers and patients are notified that their results have been uploaded and can instantly view their results. A Clinical Lab Report PDF may be downloaded by providers and patients for reporting, travel, or proof of testing.
  • The lab has access to a full customizable, searchable breakdown of all data for reporting. This includes all patient information, sample collection data, provider information and sponsor information.
  • The lab can create custom transaction reports to monitor performance and throughput. User management and messaging tools also enable customer support.

The benefits of LabDash are clear. Because manual data entry is eliminated, data is more accurate and staff strain is reduced. In addition, paperless data collection and electronic data transfer helps support HIPAA compliance and security.

LabDash empowers easy management and tracking of COVID-19 test kits and simplified reporting and analytics, driving measurable benefits across the healthcare ecosystem.

To sign up today, click here.

###

About LabDash

LabDash simplifies and speeds up the entire COVID-19 testing process for patients, providers, private sponsors, and labs. LabDash was designed and built by Concept Systems in partnership with Willamette Valley Toxicology, with a focus on the entire testing lifecycle from patient sign-ups through testing and results reporting, to billing and invoicing. Concept Systems created an easy process to ensure that customers are able to use the system; Create an account, get a QR code, and show up at the testing site: it’s that easy.

Pro AV Today

Part of this channel

Pro AV Today

Pro AV news, trends, and expert voices for the AV industry

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512